| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Hoch PH, Cattell JP, Penn... |
Effects of mescaline and lysergic acid (d-LSD-25) |
Amer. J. Psychiatry |
1952 |
| Hoch PH, Pennes HH, Catte... |
Psychoses produced by administration of drugs |
Res. Publ. Ass. Nerv... |
1953 |
| Pennes HH |
Clinical reactions of schizophrenics to sodium amytal, pervitin hydroc... |
J. Nerv. Ment. Dis. |
1954 |
| Pennes HH |
The nature of drugs with mental actions and their relation to cerebral... |
Bull. N.Y. Acad. Med... |
1957 |
| Pennes HH |
Effects of various drugs on clinical psychopathology |
Experimental psychop... |
1957 |
| Abramson HA, Sklarofsky B... |
Blocking effect of brain extract on lysergic acid diethylamide reactio... |
Science |
1957 |
| Abramson HA, Sklarofsky B... |
Lysergic acid diethylamide (LSD-25) antagonists. I. Blocking effect o... |
Arch. Neruol. Psychi... |
1957 |
| Hoch PH, Pennes HH, Catte... |
Psychoses produced by administration of drugs. (In: Chemical concepts ... |
McDowell Obolensky |
1958 |
| Mörsdorf K, Bode HH |
Zur Beeinflussung der permeabilitätssteigernden Wirkung des Serotonins... |
Arch. internat. phar... |
1959 |
| Borgstedt HH |
The effect of serotonin and LSD on the isolated dog ureter. |
Fed. Proc. |
1959 |
| Abramson HA, Gettner HH, ... |
Lysergic acid diethylamide (LSD-25) XXXIII. Effect on surfacing behav... |
J. Psychol. |
1961 |
| Borgstedt HH, Benjamin JA... |
The role of histamine in ureteral function |
J. Pharmacol. exp. T... |
1962 |
| Cates N, Broer HH, Siva D... |
Effect of lysergic acid diethylamide (LSD) and of chlorpromazine (CPZ)... |
Fed. Proc. |
1962 |
| Broer HH, Cates N, Siva D... |
Effect of d-lysergic acid diethylamide on oxygen uptake and norepineph... |
Fed. Proc. |
1963 |
| Sankar SDV, Broer HH, Cat... |
Studies on biogenic amines and psychoactive drug actions, with special... |
Trans, N.Y. Acad. Sc... |
1964 |
| Borgstedt HH, Emmel VM, B... |
The influence of serotonin and LSD-25 on the isolated, perfused canine... |
Arch. int. Pharmacod... |
1966 |
| Hirschhorn K, Cohen MM |
Nonpsychic effects of lysergic acid diethylamide |
Ann. intern. med |
1967 |
| Cohen MM, Hirschhorn K, F... |
In vivo in vitro chromosomal damage induced by LSD-25 |
New Engl J Med |
1967 |
| Cohen MM, Hirschhorn K, F... |
LSD and chromosomes |
New Engl J Med |
1968 |
| Cohen MM, Hirschhorn K, V... |
The effect of LSD-25 on the chromosomes of children exposed in utero |
Pediat. Res. |
1968 |
| Hirschhorn K, Cohen MM |
Drug-induced chromosomal aberrations |
Ann. N.Y. Acad. Sci. |
1968 |
| Hischhorn K |
LSD and chromosomal damage |
Hosp. Pract. |
1969 |
| Hsu LY, Strauss L, Hirsch... |
Chromosome abnormality in offspring of LSD user. D Trisomy with d/d t... |
J. Amer. Med. Ass. |
1970 |
| Panhuysen LHHM |
De ongewenste werkingen na het innemen van LSD |
Ned. T. Geneesk |
1970 |
| Lignelli GJ, Buchheit WA |
Necrotizing angiitis associated with drug abuse |
New Engl. J. Med. |
1971 |
| Hirschhorn ID, Winter JC |
Mescaline and lysergic acid diethylamide (LSD) as discriminative stimu... |
Psychopharmacologia ... |
1971 |
| Gettner HH, Carone PA, Ab... |
Lysergic acid diethylamide (LSD 25): XXX. Effect of pH on transport of... |
J. Psychol. |
1973 |
| Hirschhorn ID, Rosecrans ... |
A comparison of the sitimulus effects of morphine and lysergic acid di... |
Pharmacol. Riochem. ... |
1974 |
| Hirschhorn ID, Hayes RL, ... |
Discrimintaive Control of Behavior by Electrical Stimulation of the Do... |
Pharmacologist |
1974 |
| Janzik HH, Kroenert K, Gu... |
Hormonal Evaluation in Young Drug Addicts |
J.Pharmacol. |
1974 |
| Harris RA, Snell D, Loh H... |
Effects Of Hallucinogens On Operant Behavior |
Fed.Proc. |
1976 |
| Hirschhorn ID, Rosecrans ... |
Generalization of Morphine and Lysergic Acid Diethylamide (LSD) Stimul... |
Psychopharmacology (... |
1976 |
| Crowley WR, Feder HH, Mor... |
Role of monamines in sexual behavior of the female guinea pig |
Pharmacol. Biochem. ... |
1976 |
| Domelsmith LN, Munchhause... |
Lysergic Acid Diethylamide. Photoelectron Ionization Potentials as Ind... |
J.Med.Chem. |
1977 |
| Domelsmith LN, Munchhause... |
Photoelectron Spectra of Psychotropic Drugs. 1. Phenethylamines, Trypt... |
J.Am.Chem.Soc. |
1977 |
| Hirschhorn ID |
Pentazocine, Cyclazacine, and Nalorphine as Discriminative Stimuli. |
Psychopharmacology (... |
1977 |
| Keller HH, Burkard WP, da... |
Lisuride and D-LSD: Effects on the monoaminergic system in the rat bra... |
Experientia |
1977 |
| Harris RA, Snell D, Loh H... |
Effects of d-amphetamine, monomethoxy-amphetamines and hallucinogens o... |
J Pharmacol Exp Ther... |
1978 |
| Da Prada M, Pieri L, Kell... |
Effects of 5,6-Dihydroxytryptamine and 5,7-Dihydroxytryptamine on the ... |
Ann.N.Y.Acad.Sci. |
1978 |
| Keller HH, Burkard WP, Pi... |
Lisuride- and D-LSD-Induced Changes of Monoamine Turnover in the Rat B... |
Advances in Biochemi... |
1978 |
| Pieri L, Keller HH, Burka... |
Effects of lisuride and LSD on cerebral monamine systems and hallucino... |
Nature |
1978 |
| Abramson HA, Gettner HH, ... |
The intracranial injection of drugs in goldfish. I: Hallucinogens and ... |
J. Asthma Res. |
1979 |
| Abramson HA, Gettner HH |
Double bonds, aliphatic chains, and hallucinogens, update |
J. Asthma Res. |
1979 |
| Pieri L, Keller HH, Laure... |
Behavioral, Neurochemical, and Electrophysiological Effects of Lisurid... |
Lisuride and Other D... |
1983 |
| Keller HH, Bonetti EP, Pi... |
Lisuride-Induced Mounting Behavior and Effects on the Monoaminergic Sy... |
Lisuride and Other D... |
1983 |
| Spencer PS, Schaumburg HH |
Organic solvent neurotoxicityFacts and research needs |
Scand J Work Environ... |
1985 |
| Reggio PH, McGaughey GB, ... |
A rational search for the separation of psychoactivity and analgesia i... |
Pharmacol Biochem Be... |
1991 |
| Maurer HH |
On the metabolism and the toxicological analysis of methylenedioxyphen... |
Ther Drug Monit |
1996 |
| Ensslin HK, Kovar KA, Mau... |
Toxicological detection of the designer drug 3,4-methylenedioxyethylam... |
J Chromatogr B Biome... |
1996 |
| Ensslin HK, Maurer HH, Go... |
Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Is... |
Drug Metab Dispos |
1997 |
| Maurer HH, Bickeboeller-F... |
Toxicokinetics and analytical toxicology of amphetamine-derived design... |
Toxicol Lett |
2000 |
| Robertson P, DeCory HH, M... |
In vitro inhibition and induction of human hepatic cytochrome P450 enz... |
Drug Metab Dispos |
2000 |
| Kraemer T, Maurer HH |
Toxicokinetics of amphetamines: metabolism and toxicokinetic data of d... |
Ther Drug Monit |
2002 |
| Peters FT, Maurer HH, Hel... |
Prevalence of illicit drug use in plasmapheresis donors |
Vox Sang |
2003 |
| Zhou JF, Zhou YH, Zhang L... |
3,4-methylenedioxymethamphetamine (MDMA) abuse markedly inhibits acety... |
Biomed Environ Sci |
2003 |
| Zhou JF, Chen P, Zhou YH,... |
3,4-Methylenedioxymethamphetamine (MDMA) abuse may cause oxidative str... |
Free Radic Res |
2003 |
| Peters FT, Schaefer S, St... |
Screening for and validated quantification of amphetamines and of amph... |
J Mass Spectrom |
2003 |
| van der Stelt M, Hansen H... |
Biosynthesis of endocannabinoids and their modes of action in neurodeg... |
Neurotox Res |
2003 |
| Staack RF, Fritschi G, Ma... |
New designer drug 1-(3-trifluoromethylphenyl) piperazine (TFMPP): gas ... |
J Mass Spectrom |
2003 |
| Staack RF, Theobald DS, P... |
In vivo metabolism of the new designer drug 1-(4-methoxyphenyl)piperaz... |
Xenobiotica |
2004 |
| Maurer HH, Kraemer T, Spr... |
Chemistry, pharmacology, toxicology, and hepatic metabolism of designe... |
Ther Drug Monit |
2004 |
| Amstrong BD, Paik E, Chhi... |
POTENTIATION OF @L)-3,4=METHYLENEDIOXYMETHAMPHETAMINE (MDMA)-INDUCED T... |
Neuroscience Researc... |
2004 |
| Staack RF, Maurer HH |
Metabolism of designer drugs of abuse |
Curr Drug Metab |
2005 |
| Theobald DS, Staack RF, P... |
New designer drug 2,5-dimethoxy-4-ethylthio-beta-phenethylamine (2C-T-... |
J Mass Spectrom |
2005 |
| Ewald AH, Fritschi G, Bor... |
Designer drugs 2,5-dimethoxy-4-bromo-amphetamine DOB and 2,5-dimethoxy... |
J Mass Spectrom |
2006 |
| Ewald AH, Fritschi G, Mau... |
Designer drug 2,4,5-trimethoxyamphetamine (TMA-2): studies on its meta... |
J Mass Spectrom |
2006 |
| Ewald AH, Fritschi G, Mau... |
Designer drug 2,4,5-trimethoxyamphetamine TMA-2: studies on its metabo... |
J Mass Spectrom |
2006 |
| Theobald DS, Maurer HH |
Identification of monoamine oxidase and cytochrome P450 isoenzymes inv... |
Biochem Pharmacol |
2007 |
| Theobald DS, Fritschi G, ... |
Studies on the toxicological detection of the designer drug 4-bromo-2,... |
J Chromatogr B Analy... |
2007 |
| Meyer MR, Wilhelm J, Pete... |
Beta-keto amphetamines: studies on the metabolism of the designer drug... |
Anal Bioanal Chem |
2010 |
| Meyer MR, Maurer HH |
Metabolism of designer drugs of abuse: an updated review |
Curr Drug Metab |
2010 |
| Derungs A, Schietzel S, M... |
Sympathomimetic toxicity in a case of analytically confirmed recreatio... |
Clinical Toxicology |
2011 |
| Kapp FG, Maurer HH, Auwär... |
Intrahepatic cholestasis following abuse of powdered kratom (Mitragyna... |
J Med Toxicol |
2011 |
| Carroll FI, Lewin AH, Mas... |
Designer drugs: a medicinal chemistry perspective |
Ann N Y Acad Sci |
2011 |
| Carroll FI, Lewin AH, Mas... |
Designer drugs: a medicinal chemistry perspective |
Ann N Y Acad Sci |
2011 |
| Baumann MH, Partilla JS, ... |
Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV)... |
Neuropsychopharmacol... |
2013 |
| Hofmaier T, Luf A, Seddik... |
Aminorex, a metabolite of the cocaine adulterant levamisole, exerts am... |
Neurochem Int |
2013 |
| Tavakoli HR, Buchholz AC,... |
Kratom: A New Product in an Expanding Substance Abuse Market |
Fed Pract |
2016 |
| Maier J, Mayer FP, Brandt... |
DARK Classics in Chemical Neuroscience: Aminorex Analogues |
ACS Chem Neurosci |
2018 |
